Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
9.17
+0.04 (0.44%)
At close: Mar 9, 2026, 4:00 PM EDT
9.02
-0.15 (-1.61%)
After-hours: Mar 9, 2026, 6:28 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $82.96 million as of March 9, 2026. Its market cap has decreased by -40.15% in one year.
Market Cap
82.96M
Enterprise Value
120.44M
1-Year Change
-40.15%
Ranking
Category
Stock Price
$9.17
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $82.96M, a decrease of -95.60%. That is a compound annual growth rate of -25.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 82.60M | -38.63% |
| Dec 31, 2025 | 134.60M | -5.14% |
| Dec 31, 2024 | 141.90M | -21.60% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 90.16M |
| Kazia Therapeutics | 89.89M |
| PMV Pharmaceuticals | 87.27M |
| Pyxis Oncology | 85.30M |
| OKYO Pharma | 85.27M |
| Verrica Pharmaceuticals | 84.91M |
| Pliant Therapeutics | 81.73M |
| Champions Oncology | 81.51M |